全文获取类型
收费全文 | 659篇 |
免费 | 50篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 20篇 |
妇产科学 | 2篇 |
基础医学 | 56篇 |
口腔科学 | 20篇 |
临床医学 | 98篇 |
内科学 | 142篇 |
皮肤病学 | 19篇 |
神经病学 | 7篇 |
特种医学 | 91篇 |
外科学 | 36篇 |
综合类 | 64篇 |
预防医学 | 54篇 |
眼科学 | 2篇 |
药学 | 60篇 |
1篇 | |
中国医学 | 19篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 2篇 |
2022年 | 6篇 |
2021年 | 9篇 |
2020年 | 13篇 |
2019年 | 12篇 |
2018年 | 15篇 |
2017年 | 7篇 |
2016年 | 7篇 |
2015年 | 30篇 |
2014年 | 24篇 |
2013年 | 30篇 |
2012年 | 31篇 |
2011年 | 28篇 |
2010年 | 41篇 |
2009年 | 30篇 |
2008年 | 26篇 |
2007年 | 31篇 |
2006年 | 12篇 |
2005年 | 12篇 |
2004年 | 7篇 |
2003年 | 14篇 |
2002年 | 5篇 |
2001年 | 8篇 |
2000年 | 2篇 |
1999年 | 9篇 |
1998年 | 29篇 |
1997年 | 24篇 |
1996年 | 32篇 |
1995年 | 24篇 |
1994年 | 24篇 |
1993年 | 15篇 |
1992年 | 10篇 |
1991年 | 11篇 |
1990年 | 11篇 |
1989年 | 18篇 |
1988年 | 18篇 |
1987年 | 12篇 |
1986年 | 8篇 |
1985年 | 11篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 9篇 |
1981年 | 3篇 |
1980年 | 8篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 7篇 |
1975年 | 3篇 |
1954年 | 1篇 |
排序方式: 共有713条查询结果,搜索用时 0 毫秒
31.
目的探讨耳穴贴压治疗单纯性肥胖症的临床效应。方法应用耳穴贴压治疗单纯性肥胖症,观察治疗前后患者肥胖指标、血脂指标等的变化,评测耳穴贴压减肥的效果。结果各项指标在治疗前后差异均有显著性。结论耳穴贴压治疗单纯性肥胖,疗效确切,对患者各项生理指标有良性调节作用。 相似文献
32.
目的:研究肝郁痰凝型乳腺癌的钼靶X线影像特点,探讨其病理基础。方法:观察41例中医证型为肝郁痰凝型、术后病理检查结果为乳腺癌患者的钼靶X线影像表现,对其病理学基础进行分析。结果:41例肝郁痰凝型乳腺癌中,乳腺类型以致密型及混合型居多(占78%)。异常血管征及透环征出现频率较高(占80%以上)。腋淋巴结转移出现频率偏低(占12%)。结论:(1)肝郁痰凝型乳腺癌患者,乳腺密度多偏高,可能与较多发生在绝经期前有关。(2)肿瘤周围透亮环征象及异常血管征象出现频率较高,表明此型患者肿块周围脂肪代谢异常较为普遍及血管生长刺激因子分泌较多。(3)腋窝淋巴结转移者所占比例较小,可能是由于此类患者多属于癌变早、中期,相对气血不足或脾肾虚弱等正虚表现不明显。 相似文献
33.
目的评价中心静脉导管留置治疗胸腔积液的疗效。方法257例胸腔积液患者分为两组,治疗组207例,应用胸腔留置中心静脉导管治疗;对照组50例,常规胸穿抽液治疗,观察并比较不同治疗方法的疗效、并发症等指标。结果两组对比多项指标差异有显著性(P〈0.05)。结论采用中心静脉导管治疗胸腔积液可减少胸穿次数、降低反应,提高治愈率。 相似文献
34.
35.
36.
M?ChakravarthyEmail author V?Jawali M?Manohar TA?Patil K?Jayaprakash NV?Shivananda 《Indian Journal of Thoracic and Cardiovascular Surgery》2003,19(3):151-154
Conclusion Our case report highlights the possibility of tackling mediastinal, pericardial and pleural problems with regional anesthesia
alone even if the surgery requires opening of the pleura. 相似文献
37.
陶瑞卿 《四川生殖卫生学院学报》2007,(6):32-35,55
公共产品涉及千家万户的切身利益,近10多年来,部分公共产品价格变化又多以超过国民经济发展速度提高,怎样正确认识和判断其价格的合理性,具有十分重要的现实意义。本文分析了我国公共产品的价格类型,定价机制,阐明了我国公共产品的价格约束制度构建的主要内容,希望为政府及相关部门工作提供有益的帮助。 相似文献
38.
39.
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders. 总被引:1,自引:0,他引:1
Leuprorelin (leuprolide acetate) is a synthetic analogue of gonadotrophin-releasing hormone (GnRH) [luteinising hormone-releasing hormone (LHRH)] which initially stimulates luteinising hormone (LH) and hence testicular androgen release; continuous administration then results in profound suppression of these hormones. Testosterone levels associated with castration are attained within 3 to 4 weeks. A biodegradable subcutaneous or intramuscular depot formulation of leuprorelin 3.75 or 7.5 mg, which releases the drug at a constant rate over 28 days, is available and may be preferred over daily subcutaneous injections. The progression of previously untreated advanced prostatic cancer is delayed in 70 to 90% of men receiving leuprorelin, with median survival of approximately 2 years. The efficacy of leuprorelin is equivalent to that of estrogen therapy, but the tolerability of the GnRH analogue is far better. In contrast to most other studies of GnRH agonists, a slight survival advantage has been reported for combined treatment with leuprorelin and the antiandrogen flutamide. Small noncomparative trials reveal that leuprorelin also causes regression of benign hyperplastic prostate tissue with corresponding relief of obstructive, but not irritative, symptoms although continuous treatment is necessary to maintain remission. Impotence and flushing occur in most leuprorelin recipients but, unlike diethylstilbestrol (stilboestrol), cardiovascular toxicity and gynaecomastia are not significant problems. Symptom flare, usually manifested as bone pain in prostate cancer patients and exacerbation of obstructive symptoms in those with benign prostatic hypertrophy, can occur in 4 to 29% at the beginning of treatment. Leuprorelin treatment is therefore an established effective palliative measure in men with previously untreated advanced prostatic cancer, and may have a role in those with benign hypertrophy who are unfit for surgery. 相似文献
40.
Faecal endogenous loss of calcium in young sheep 总被引:1,自引:0,他引:1
1. Two groups of eight 6-7-month-old wether lambs were offered either a frozen ryegrass (Lolium perenne L.)-white clover (Trifolium repens L.) pasture or a ryegrass-white clover hay, containing 12.1 and 6.4 g calcium/kg dry matter (DM) respectively. Within groups the amounts offered to individual sheep ranged from 0.5 to 2.0 times the estimated maintenance energy requirements. 2. A single intravenous injection of 150 microCi 45Ca as CaCl2.2H2O, and stable balances were used to determine absorption, faecal endogenous loss and balance of Ca. 3. Faecal endogenous loss of Ca increased by 1.2 mg/kg body-weight (W) per d with each g/kg W per d increase in DM intake regardless of the diet. At any DM intake the mean faecal endogenous loss was 5.5 mg/kg W per d higher in the sheep offered the frozen herbage diet when compared with those on the hay diet. At any Ca intake the mean faecal endogenous loss was 6.9 mg/kg W higher in sheep offered the hay diet compared with those on the frozen herbage. 4. At feeding levels of about 1.5-2 times the estimated maintenance energy requirement the observed faecal endogenous loss of Ca ranged from 35 to 50 mg/kg W per d, which is two- to threefold greater than the present estimate of the Agricultural Research Council (1980) of 16 mg/kg W per d.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献